Search clinical trials for: Dual Growth Factor

Total 34298 results

University of Pittsburgh
University of Miami

Completed

Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury (SCI)

Spinal Cord Injuries

United States
Meir Medical Center

Withdrawn

Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear

MCL Tear

Israel
Meir Medical Center

Completed

Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation

Patella-Dislocation

Israel
National Cancer Institute (NCI)

Completed

Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma

Adult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Recurrent Adult Brain Tumor

United States
Cristina Gasparetto
Celgene

Active, not recruiting

Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma

Multiple Myeloma

United States
Calico Life Sciences LLC
AbbVie

Recruiting

A Phase 1 Study With ABBV-CLS-484 in Subjects With Locally Advanced or Metastatic Tumors

Advanced Solid Tumor Cancer

United States, Korea, Republic of, Spain, Israel, Japan, France
Wright State University

Recruiting

Gene Expression Changes In Young and Geriatric Skin

Aging | UVB Phototherapy Burn | Insulin-like Growth Factor 1

United States
Arbeitsgemeinschaft medikamentoese Tumortherapie

Completed

Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Multiple Myeloma

Czechia, Austria, Germany
Universidade Federal de Alfenas

Completed

Digital Planning and Guided Dual Technique in Aesthetic Crown Lengthening

Tooth Eruption Disorder

Brazil
Universidad Nacional de Colombia

Completed

Introduction Study of Dual HIV & Syphilis Rapid Diagnostic Tests in Antenatal Clinics in Colombia

HIV | Syphilis

Colombia
Istanbul Medipol University Hospital

Completed

Effects of Training on Fall Risk and Balance Performances

Accidental Falls

Turkey
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Resting Metabolic Rate, Fat Distribution, Endocrine and Metabolic Features in Polycystic Ovary Syndrome

Polycystic Ovary Syndrome
Chinese PLA General Hospital

Unknown

Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Non-healing Wounds

Mesenchymal Stem Cell-derived Bioactivator for Treating Chronic Wounds

China
University of Manitoba
Canadian Institutes of Health Research (CIHR)

Recruiting

Building Regulation in Dual Generations 2022-2025 (BRIDGE)

Child Development | Child Mental Disorder | Maternal Depression | Self-Regulation, Emotion

Canada
Atılım University

Not yet recruiting

Cognitive - Motor Dual Task and Swallowing

DUAL TASK | DEGLUTİTİON | COGNİTİVE FUNCTİON | ACTİVİTİES OF DAİLY LİVİNG
University Department of Geriatric Medicine FELIX...

Not yet recruiting

SARCOPEDIA - Sarcopenia Diagnostics in Aging Medicine (SARCOPEDIA)

Muscle Weakness | Frailty | Sarcopenia
Chinese PLA General Hospital

Unknown

A Feasibility and Safety Study of Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cell Immunotherapy for Relapsed or Refractory Leukemia and Lymphoma

B Cell Lymphoma | B Cell Leukemia

China
Yonsei University

Completed

Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels

Hypertriglyceridemia

Korea, Republic of
Federal University of Minas Gerais

Completed

Effects of Dual-task Exercises on Gait Parameters and Cognitive Function in Elderly Women: A Randomized Controlled Trial

Healthy

Brazil
CardioVascular BioTherapeutics, Inc.

Not yet recruiting

Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease

Myocardial Ischemia | Coronary Disease | Coronary Heart Disease | Coronary Arteriosclerosis
Sun Pharmaceutical Industries Limited

Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010) (reSURFACE 1)

Plaque Psoriasis
Universitaire Ziekenhuizen KU Leuven

Recruiting

Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy (SOPRANO-CD)

Crohn Disease

Belgium, Italy
Shenyang Tenth People's Hospital
Beijing Tsinghua Changgeng Hospital

Not yet recruiting

Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC

Advanced HCC
Jiangxi Provincial People's Hopital

Not yet recruiting

Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis

Dermatomyositis

China
Fundación Pública Andaluza para la gestión de la...

Unknown

Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results.

Mantle Cell Lymphoma

Spain
Celgene

Completed

Phase 1 Study OF CDC-501 in Patients With Solid Tumors

Neoplasms

United States
Celgene

Completed

A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma

Peripheral T-cell Lymphoma | Adult T-cell Leukemia-Lymphoma

Japan
AHS Cancer Control Alberta
Alberta Cancer Foundation; Celgene Corporation

Completed

A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma

T-cell Lymphoma

Canada
French National Agency for Research on AIDS and...
Celgene Corporation

Terminated

Lenalidomide in Kaposi Disease Associated With HIV Infection (LENAKAP)

HIV Infection Associated Kaposi Disease

France
Stryker Craniomaxillofacial
Fortrea

Enrolling by invitation

Adherus™ Dural Sealant in Spinal Procedures

Spinal Duraplasty

United States
The Lymphoma Academic Research Organisation

Completed

Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)

T-cell Lymphoma

France, Belgium
Celgene

Completed

A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia

Leukemia, Myeloid

United States, Canada
National Cancer Institute (NCI)
Celgene Corporation

Terminated

Lenalidomide Maintenance Therapy for Multiple Myeloma

Multiple Myeloma

United States
National Taiwan University Hospital

Completed

Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma

Liver Cancer

Taiwan
PETHEMA Foundation

Terminated

LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)

AML

Spain
University of Alabama at Birmingham

Terminated

Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas

Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Peripheral T-cell Lymphomas | Adult T-cell Leukemia | Adult T-cell Lymphoma | Peripheral T-cell Lymphoma Unspecified | T/Null Cell Systemic Type | Cutaneous t-Cell Lymphoma With Nodal/Visceral Disease

United States
Roswell Park Cancer Institute

Recruiting

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Pneumonia | Chronic Obstructive Pulmonary Disease | Lung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IB Lung Cancer AJCC v8

United States
Milton S. Hershey Medical Center

Completed

Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery (OGF)

Pancreatic Cancer

United States
University Hospital, Caen

Not yet recruiting

Acute Lymphoblastic Leukaemia Related to Lenalidomide (LenALL)

Cancer

France
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Lenalidomide Maintenance in Plasma Cell Myeloma

Plasma Cell Myeloma

United States
Dartmouth-Hitchcock Medical Center
Celgene Corporation

Terminated

Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance (MGUS)

Neuropathy | Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)

United States
ARCAGY/ GINECO GROUP

Completed

A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse (REV)

Ovarian Cancer Recurrent

France
University Hospital, Bordeaux

Completed

Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma (REVALLO)

Multiple Myeloma

France
Hospital Universitari Vall d'Hebron Research Institute

Completed

Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus (ORDI-02)

Cutaneous Lupus

Spain
Medical University of Vienna

Unknown

Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type

MALT Lymphoma

Austria
Florida Academic Dermatology Centers
Celgene Corporation

Unknown

Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma (REvMM2009)

Cutaneous T Cell Lymphoma

United States
University College of Northern Denmark

Recruiting

Safe Return to Play After Concussion

Sports Injury | Concussion, Brain

Denmark
Dana-Farber Cancer Institute

Recruiting

Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture

Bone Mineral Density | Childhood Cancer Survivors

United States
Fundacion SEIMC-GESIDA

Completed

A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection (InSTINCT)

HIV Infections

Spain
Royan Institute

Completed

The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response

Reproductive Techniques, Assisted | Ovarian Stimulation

Iran, Islamic Republic of

Search clinical trials for: Dual Growth Factor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations